Literature DB >> 11543750

Polycystic ovarian syndrome (PCOS) and insulin resistance.

K H Park1, J Y Kim, C W Ahn, Y D Song, S K Lim, H C Lee.   

Abstract

OBJECTIVES: Polycystic ovary syndrome (PCOS) presents a high risk of developing type 2 diabetes mellitus. We studied a group of women with PCOS and evaluated this defect in insulin action.
METHODS: The study population consisted of nine PCOS women, six obese type 2 diabetic patients, and five controls whose body mass index (BMI) was similar to that of the nine PCOS women. The 75-g oral glucose tolerance test (OGTT) and the hyperinsulinemic euglycemic glucose clamp test were performed. Clinical characteristics and the metabolic profiles, including the insulin sensitivity index (ISI), were compared.
RESULTS: PCOS women showed significantly elevated insulin responses during OGTT, but their blood glucose levels were comparable with the controls. The subjects with PCOS had more insulin resistance than the other groups. There was no difference among the groups in terms of clinical characteristics and metabolic profiles, except age, luteinzing hormone (LH), testosterone, and sex hormone binding globulin (SHBG).
CONCLUSION: We conclude that PCOS women have significant insulin resistance which is independent of adiposity.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11543750     DOI: 10.1016/s0020-7292(01)00442-8

Source DB:  PubMed          Journal:  Int J Gynaecol Obstet        ISSN: 0020-7292            Impact factor:   3.561


  8 in total

1.  The effect of metformin treatment on leukocyte telomere length in patients with polycystic ovary syndrome: a prospective case-control study.

Authors:  Özlem Kayacık Günday; Müjgan Özdemir Erdoğan; Ayşen Pehlivan; Mehmet Yılmazer
Journal:  J Assist Reprod Genet       Date:  2022-07-21       Impact factor: 3.357

2.  TNF-α haplotype association with polycystic ovary syndrome - a South Indian study.

Authors:  M L N Deepika; K Ranjith Reddy; A Yashwanth; V Usha Rani; K Prasanna Latha; Parveen Jahan
Journal:  J Assist Reprod Genet       Date:  2013-08-23       Impact factor: 3.412

3.  Metformin therapy in a hyperandrogenic anovulatory mutant murine model with polycystic ovarian syndrome characteristics improves oocyte maturity during superovulation.

Authors:  Mary E Sabatini; Lankai Guo; Maureen P Lynch; Joseph O Doyle; Hojoon Lee; Bo R Rueda; Aaron K Styer
Journal:  J Ovarian Res       Date:  2011-05-23       Impact factor: 4.234

4.  The prevalence of metabolic syndrome and insulin resistance according to the phenotypic subgroups of polycystic ovary syndrome in a representative sample of Iranian females.

Authors:  Ferdous Mehrabian; Behnaz Khani; Roya Kelishadi; Narges Kermani
Journal:  J Res Med Sci       Date:  2011-06       Impact factor: 1.852

5.  Insulin resistance and obesity among infertile women with different polycystic ovary syndrome phenotypes.

Authors:  Moamar Al-Jefout; Nedal Alnawaiseh; Aiman Al-Qtaitat
Journal:  Sci Rep       Date:  2017-07-13       Impact factor: 4.379

Review 6.  Role of Lipotoxicity and Contribution of the Renin-Angiotensin System in the Development of Polycystic Ovary Syndrome.

Authors:  Alexandre Connolly; Samuel Leblanc; Jean-Patrice Baillargeon
Journal:  Int J Endocrinol       Date:  2018-06-03       Impact factor: 3.257

7.  C-Peptide Inhibits Decidualization in Human Endometrial Stromal Cells via GSK3β-PP1.

Authors:  Sana Abdul Khaliq; Mi-Ock Baek; Hye-Jeong Cho; Seung Joo Chon; Mee-Sup Yoon
Journal:  Front Cell Dev Biol       Date:  2020-11-30

8.  Relationship between Serum Lipoprotein Ratios and Insulin Resistance in Polycystic Ovary Syndrome.

Authors:  Shou-Kui Xiang; Fei Hua; Ying Tang; Xiao-Hong Jiang; Qi Zhuang; Feng-Juan Qian
Journal:  Int J Endocrinol       Date:  2012-06-25       Impact factor: 3.257

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.